LGS A MONTHLY NEWSLETTER FOR HEALTH CARE PROVIDERS TREATING PATIENTS WITH LENNOX-GASTAUT SYNDROME www.lgshope.com

First Page		Document Content
Date: 2013-11-05 11:19:03 Seizure types Anticonvulsants Neurological disorders Organochlorides Lennox–Gastaut syndrome Generalised epilepsy Rufinamide Clobazam Epileptic seizure Epilepsy Brain Central nervous system		LGS A MONTHLY NEWSLETTER FOR HEALTH CARE PROVIDERS TREATING PATIENTS WITH LENNOX-GASTAUT SYNDROME www.lgshope.com Add to Reading List Source URL: www.lgshope.com Download Document from Source Website File Size: 346,20 KB Share Document on Facebook

$Articles Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials Philippe Ryvlin*, Michel Cuchera$	Articles Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials Philippe Ryvlin*, Michel Cuchera DocID: 1pxrC - View Document
	UCB files VIMPAT® (lacosamide) in the US as monotherapy treatment in adult epilepsy patients with partial-onset seizures DocID: 1oBvh - View Document
	DOC Document DocID: 10bac - View Document
	SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of DocID: YWKF - View Document
	Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MA[removed]Tel[removed]News Release Contact: DocID: M62o - View Document